NL8120434A - Nieuwe galenische vorm van fenofibraat, werkwijze ter bereiding alsmede de geneeskundige toepassing daarvan. - Google Patents

Nieuwe galenische vorm van fenofibraat, werkwijze ter bereiding alsmede de geneeskundige toepassing daarvan. Download PDF

Info

Publication number
NL8120434A
NL8120434A NL8120434A NL8120434A NL8120434A NL 8120434 A NL8120434 A NL 8120434A NL 8120434 A NL8120434 A NL 8120434A NL 8120434 A NL8120434 A NL 8120434A NL 8120434 A NL8120434 A NL 8120434A
Authority
NL
Netherlands
Prior art keywords
fenofibrate
granules
derivatives
neutral
weight
Prior art date
Application number
NL8120434A
Other languages
English (en)
Dutch (nl)
Original Assignee
Deshors
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Deshors filed Critical Deshors
Publication of NL8120434A publication Critical patent/NL8120434A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
NL8120434A 1980-11-19 1981-11-18 Nieuwe galenische vorm van fenofibraat, werkwijze ter bereiding alsmede de geneeskundige toepassing daarvan. NL8120434A (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR8024568 1980-11-19
FR8024568A FR2494112B1 (zh) 1980-11-19 1980-11-19
FR8100148 1981-11-18
PCT/FR1981/000148 WO1982001649A1 (fr) 1980-11-19 1981-11-18 Nouvelle forme galenique du fenofibrate, son procede d'obtention, son application comme medicament

Publications (1)

Publication Number Publication Date
NL8120434A true NL8120434A (nl) 1982-10-01

Family

ID=9248140

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8120434A NL8120434A (nl) 1980-11-19 1981-11-18 Nieuwe galenische vorm van fenofibraat, werkwijze ter bereiding alsmede de geneeskundige toepassing daarvan.

Country Status (8)

Country Link
EP (1) EP0065531A1 (zh)
AT (1) AT387517B (zh)
BE (1) BE891129A (zh)
DE (1) DE3152519C2 (zh)
FR (1) FR2494112B1 (zh)
IT (1) IT1144948B (zh)
NL (1) NL8120434A (zh)
WO (1) WO1982001649A1 (zh)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2554718B1 (fr) * 1983-11-14 1986-04-04 Ethypharm Sa Nouvelles formes galeniques du sulpiride utilisables par voie orale
FR2556964A1 (fr) * 1983-12-23 1985-06-28 Ile De France Nouvelles formes galeniques du sulpiride utilisables par voie orale
JPS60221078A (ja) * 1984-04-18 1985-11-05 Morinaga Milk Ind Co Ltd 有用微生物粉末の粒状製品およびその製造法
IT1180507B (it) * 1984-06-29 1987-09-23 Roberto Valducci Procedimento per la preparazione di etofibrato o sostanze di pari o simili caratteristiche, in microgunuli-ritardo e prodotto ottenuto con tale procedimento
FR2602423B1 (fr) * 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
FR2627696B1 (fr) * 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
FR2737121B1 (fr) * 1995-07-27 1997-10-03 Cl Pharma Nouvelles formulations galeniques du fenofibrate et leurs applications
DE19608750A1 (de) * 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
FR2758461A1 (fr) * 1997-01-17 1998-07-24 Pharma Pass Composition pharmaceutique presentant une biodisponibilite elevee et son procede de preparation
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
DE19858789A1 (de) 1998-12-18 2000-06-21 Bayer Ag Kombination von Cerivastatin und Fibraten
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US6180138B1 (en) 1999-01-29 2001-01-30 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6383517B1 (en) 1999-01-29 2002-05-07 Abbott Laboratories Process for preparing solid formulations of lipid-regulating agents with enhanced dissolution and absorption
US6368622B2 (en) 1999-01-29 2002-04-09 Abbott Laboratories Process for preparing solid formulations of lipid regulating agents with enhanced dissolution and absorption
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
US7863331B2 (en) 1999-07-09 2011-01-04 Ethypharm Pharmaceutical composition containing fenofibrate and method for the preparation thereof
FR2795961B1 (fr) 1999-07-09 2004-05-28 Ethypharm Lab Prod Ethiques Composition pharmaceutique contenant du fenofibrate micronise, un tensioactif et un derive cellulosique liant et procede de preparation
US6531158B1 (en) 2000-08-09 2003-03-11 Impax Laboratories, Inc. Drug delivery system for enhanced bioavailability of hydrophobic active ingredients
FR2819720B1 (fr) 2001-01-22 2004-03-12 Fournier Lab Sa Nouveaux comprimes de fenofibrate
WO2004028506A1 (en) * 2002-09-24 2004-04-08 Ranbaxy Laboratories Limited Oral pharmaceutical compositions of fenofibrate having high bioavailability
CA2505521A1 (en) * 2002-11-22 2004-06-10 Meiji Seika Kaisha, Ltd. Granular composition and process for producing the same
DE60313359T2 (de) * 2002-12-17 2008-01-03 Abbott Gmbh & Co. Kg Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
EP1832285A1 (en) * 2002-12-17 2007-09-12 Abbott GmbH & Co. KG Formulation comprising fenofibric acid or a physiologically acceptable salt thereof
EP1643975A2 (en) * 2003-07-02 2006-04-12 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US8062664B2 (en) 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
EP1785133A1 (en) 2005-11-10 2007-05-16 Laboratoires Fournier S.A. Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
WO2008075320A2 (en) * 2006-12-21 2008-06-26 Ranbaxy Laboratories Limited Antilipidemic pharmaceutical compositions and process for preparation thereof
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
US20180147215A1 (en) 2016-11-28 2018-05-31 Lipocine Inc. Oral testosterone undecanoate therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2963402A (en) * 1955-01-18 1960-12-06 Nysco Lab Inc Sustained release medicament
FR1347413A (fr) * 1963-01-29 1963-12-27 Italnysco S P A Sphérules ou globules à action étalée et procédé pour leur préparation
GB1415295A (en) * 1971-10-14 1975-11-26 Orchimed Sa Substituted phenoxy-alkyl-carboxylic acids and derivatives thereof
US3773920A (en) * 1971-07-14 1973-11-20 Nikken Chemicals Co Ltd Sustained release medicinal composition
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
ZA765931B (en) * 1975-10-10 1977-09-28 Squibb & Sons Inc Controlled release tablet
FR2313915A1 (fr) * 1976-01-26 1977-01-07 Corneille Gilbert Nouvelle forme galenique d'administration de la vincamine et de ses derives, son procede de preparation et medicaments comprenant cette nouvelle forme
LU77353A1 (zh) * 1977-05-16 1979-01-19
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention

Also Published As

Publication number Publication date
EP0065531A1 (fr) 1982-12-01
WO1982001649A1 (fr) 1982-05-27
IT1144948B (it) 1986-10-29
IT8125185A0 (it) 1981-11-19
ATA906481A (de) 1988-07-15
BE891129A (fr) 1982-05-17
DE3152519C2 (de) 1990-11-22
AT387517B (de) 1989-02-10
FR2494112A1 (zh) 1982-05-21
DE3152519T1 (de) 1983-12-29
FR2494112B1 (zh) 1986-01-10

Similar Documents

Publication Publication Date Title
NL8120434A (nl) Nieuwe galenische vorm van fenofibraat, werkwijze ter bereiding alsmede de geneeskundige toepassing daarvan.
EP0431877B1 (en) Cimetidine pharmaceutical compositions
EP0142561B1 (en) Long-acting nifedipine preparation
US8563042B2 (en) Pharmaceutical composition containing fenofibrate and method for the preparation thereof
RU2072840C1 (ru) Твердая лекарственная форма пролонгированного действия для лечения сердечно-сосудистых заболеваний
KR100371523B1 (ko) 테오필린 서방성 정제
JP2560019B2 (ja) 活性化合物の放出を制御する新規な製剤およびその製造法
JP2930875B2 (ja) γ−ヒドロキシ酪酸塩による制御放出能をもつ薬化学組成物
EP0523847B1 (en) Taste mask coating for preparation of chewable pharmaceutical tablets
JP2571693B2 (ja) フェノフィブレ−ト含有顆粒状医薬品及びその製法
KR100391104B1 (ko) 생체 이용율이 높은 페노피브레이트 제약학적 조성물과 그의제조방법
US4316884A (en) Sustained release pharmaceutical formulation
PL172571B1 (pl) Doustny preparat morfiny PL PL PL
BG60638B1 (bg) Лекарствена форма с контролирано освобождаване иметод за получаването й
Cheymol et al. The pharmacokinetics of dexfenfluramine in obese and non-obese subjects.
US4803080A (en) Sustained-release theophylline formulation
CA1336069C (en) Chewable medicament tablet containing means for taste masking
JPS635020A (ja) 制御放出性イブプロフエン製剤
FI88872B (fi) Foerfarande foer framstaellning av sferoider, som aostadkommer laongvarig foerdroejd frigoering av en som kalciumkanalblockerare anvaend dihydropyridin
CH672735A5 (zh)
Munday et al. In vitro-in vivo correlation studies on a novel controlled release theophylline delivery system and on Theo-Dur tablets
GB2159715A (en) Pharmaceutical composition in sustained release unit dose form and process for its preparation
JPH024575B2 (zh)
Cox et al. Bioavailability studies with ciglitazone in beagles I. Effect of a meal on the bioavailability of three ciglitazone dosage forms
Chang New product formulations, pharmacokinetics and bioavailability of dyphylline